Chemotherapy response score is a prognostic tool in advanced stage endometrial cancer patients treated with neoadjuvant chemotherapy

MLA

Nita K. Lee, et al. “Chemotherapy Response Score Is a Prognostic Tool in Advanced Stage Endometrial Cancer Patients Treated with Neoadjuvant Chemotherapy.” Gynecologic Oncology, vol. 159, Nov. 2020, p. e26. EBSCOhost, https://doi.org/10.1016/j.ygyno.2020.07.068.

APA

Nita K. Lee, Ricardo R. Lastra, S.D. Yamada, Chuanhong Liao, Isabel Lazo, Ina Jani, Katherine C. Kurnit, & Katherine Brito. (2020). Chemotherapy response score is a prognostic tool in advanced stage endometrial cancer patients treated with neoadjuvant chemotherapy. Gynecologic Oncology, 159, e26. https://doi.org/10.1016/j.ygyno.2020.07.068

Chicago

Nita K. Lee, Ricardo R. Lastra, S.D. Yamada, Chuanhong Liao, Isabel Lazo, Ina Jani, Katherine C. Kurnit, and Katherine Brito. 2020. “Chemotherapy Response Score Is a Prognostic Tool in Advanced Stage Endometrial Cancer Patients Treated with Neoadjuvant Chemotherapy.” Gynecologic Oncology 159 (November): e26. doi:10.1016/j.ygyno.2020.07.068.